FDA issues notice on use of doxycycline and penicillin G procaine in treatment of anthrax Nov. 5, 2001
ISIS-3521-containing combinations effective, well tolerated in NSCLC according to phase I/II data Nov. 5, 2001
Maxim to conduct phase II trial of Ceplene in triple combination therapy for hepatitis C Nov. 5, 2001
RSS